Vinva Investment Management Ltd Purchases 7,837 Shares of MetLife, Inc. $MET

Vinva Investment Management Ltd raised its position in shares of MetLife, Inc. (NYSE:MET) by 19.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 47,631 shares of the financial services provider’s stock after purchasing an additional 7,837 shares during the quarter. Vinva Investment Management Ltd’s holdings in MetLife were worth $3,909,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Norges Bank bought a new position in shares of MetLife during the 2nd quarter valued at approximately $756,104,000. Vanguard Group Inc. increased its position in MetLife by 13.3% in the third quarter. Vanguard Group Inc. now owns 64,749,521 shares of the financial services provider’s stock worth $5,333,418,000 after purchasing an additional 7,578,199 shares during the last quarter. ABN AMRO Bank N.V. purchased a new stake in MetLife during the second quarter valued at $178,669,000. Amundi raised its stake in MetLife by 40.2% during the second quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock valued at $361,265,000 after purchasing an additional 1,292,107 shares in the last quarter. Finally, First Trust Advisors LP lifted its position in MetLife by 173.4% during the third quarter. First Trust Advisors LP now owns 1,641,253 shares of the financial services provider’s stock valued at $135,190,000 after purchasing an additional 1,040,894 shares during the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Price Performance

MET stock opened at $71.83 on Monday. The stock has a market cap of $46.84 billion, a PE ratio of 15.28, a P/E/G ratio of 0.66 and a beta of 0.76. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $85.00. The company has a 50-day moving average price of $77.20 and a 200 day moving average price of $78.72. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter last year, the firm earned $2.08 earnings per share. The firm’s quarterly revenue was up 27.6% compared to the same quarter last year. Equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be paid a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Tuesday, February 3rd. MetLife’s dividend payout ratio (DPR) is currently 48.30%.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

Analyst Ratings Changes

A number of analysts have recently weighed in on MET shares. Evercore set a $95.00 target price on shares of MetLife in a report on Tuesday, February 10th. Morgan Stanley lowered their price target on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Wells Fargo & Company reduced their price objective on MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Weiss Ratings upgraded MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 20th. Finally, Mizuho set a $100.00 price objective on MetLife in a research note on Thursday, February 12th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $94.18.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.